Customer information update COVID-19
November 24, 2020

Dear Customer,
I reach out to you to give an update on how COVID-19 effects Suzuki Garphyttan at this moment.
SG has activities in six countries (Sweden, USA, Mexico, UK, Germany, and China). All plants and offices are up and running with only a few cases of COVID-19 known among our employees.
China: There is in general very few cases on national level . Our production is not affected at all. Demand and production are on a very high level.
Sweden: There is a second wave ongoing with a lot of local restrictions. Single cases have occurred within our company and been isolated with no further cases. Extra measures has been taken to avoid any contact at work such as virtual meetings, safe distance, restrictions in cantinas etc. We have had high level of short-term absence due to own mild symptoms, infected relatives or kids with flu symptoms. But production is on a steady level thanks to employees that has been able to work over-time.
UK: Second wave ongoing with National lockdown in place now. Extra measures and restrictions in place within our company to ensure site continues to remain COVID-19 free. Staggered shift pattern, external visitors and work from home protocol, daily disinfection and other added restrictions continue to be in place and are continually monitored. Demand and production are on a good level.
Germany: Second wave ongoing with a lot of local restrictions and travel bans. Virtual meetings and lot more work from home are measures taken within the company.
USA: Cases continues to increase all over USA. Single cases have occurred within our company and been isolated with no further cases. Demand and production are on a high level.
Mexico: Cases continues to increase in general. Demand and production are on a high level within SG.
We monitor the status and will update our information regularly. For questions or more information please do not hesitate to reach out to your SG contact.
Best regards,
Jonas Blomdahl
Chief Marketing Officer, Suzuki Garphyttan